LivaNova's Q2 performance and increased 2023 guidance indicate the company's ability to adapt to market challenges and capitalize on growth opportunities. The Fast Five hosts discuss the company's financial performance, which segment had the greatest growth and what the CEO had to say about the quarterly earnings.

Olympus recently launched its EasySuite ES-IP system for procedure room visualization and integration in the U.S. Whooley explains some of the features and capabilities of the new system and the benefits of using the platform in medical procedures.

The positive results from the feasibility study of Glucotrack's implantable continuous glucose monitoring (CGM) system showcase the potential of implantable devices to transform diabetes management. Hear the feasibility study results and the key differentiators of the CGM in today's episode.

Teleflex's decision to acquire Palette Life Sciences reflects its strategic focus on expanding its urology product portfolio and enhancing its position in the urological care market. Whooley and Kirsh discuss the deal's value, the technology Palette Life Sciences develops and how Teleflex will incorporate the technology into its portfolio.

The FDA said an Abbott recall involving its Amplatzer steerable delivery sheath is Class I, its most serious level. The Fast Five hosts explain how many devices are involved in the recall and if there have been any reports of incidents so far.

Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.